Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Clinical trial NCT03583710 · RECRUITING

Trial details

NCT number: NCT03583710
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

ENSAT Stage I Adrenal Cortex Carcinoma ENSAT Stage II Adrenal Cortex Carcinoma ENSAT Stage III Adrenal Cortex Carcinoma

Start date: 2018-08-20
Primary completion: 2029-01-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.